FindTrial
Sign In

Efficacy of quetiapine in behavioral and psychological symptoms of Alzheimer's disease patients

Efficacy of quetiapine in behavioral and psychological symptoms of Alzheimer's disease patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16008425
Enrollment
Unknown
Registered
2016-05-06
Start date
2016-05-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Quetiapine therapy group:Quetiapine
Memantine therapy group:Memantine

Sponsors

Changning Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) AD patients with BPSD over the age of 65; (2) AD patients be able to complete the MMSE and other scales.

Exclusion criteria

Exclusion criteria: (1) patients suffering a serious physical illness such as cancer, severe hypertension, diabetes; (2) those who can not complete the assessment because of poor hearing and vision.

Design outcomes

Primary

MeasureTime frame
Neuropsychiatric Inventory;Activity of Daily Living Scale;Treatment Emergent Symptom Scale;Berg balance scale;—

Countries

China

Contacts

Public ContactLi Ting

Changning Mental Health Center

liting2319@163.com+86 15821969844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026